#ibrx

[thefinancecompass]

ImmunityBio, Inc. (IBRX)

ImmunityBio (IBRX) outlook covering core growth engines, ANKTIVA revenue, pipeline risks, bull vs bear case, and long-term investor value.

[fmarkets]

Unusual Trends in IBRX Behavior Detected During Financial Period Closure on Dec 31, 2023 https://csimarket.com/stocks/news.php?code=IBRX&date=2024-03-19224727&utm_source=dlvr.it&utm_medium=tumblr

[nsebullcom]

Tuesday 6/6 Insider Buying Report: IBRX, FSCO

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. On Monday, ImmunityBio's Director, Michael D. Blaszyk, made a $198,023 buy of IBRX, purchasing 71,915 shares at a cost of $2.75 a piece. ImmunityBio is trading up about 5.7% on the day Tuesday. And at FS Credit Opportunities, there was insider buying on Thursday, by David J. Adelman who bought 40,000 shares at a cost of $4.55 each, for a total investment of $182,000. Before this latest buy, Adelman bought FSCO at 3 other times during the past year, for a total cost of $692,343 at an average of $4.52 per share. FS Credit Opportunities is trading up about 0.2% on the day Tuesday. Adelman was up about 3.1% on the buy at the high point of today's trading session, with FSCO trading as high as $4.69 in trading on Tuesday.

VIDEO: Tuesday 6/6 Insider Buying Report: IBRX, FSCO The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Source link Read the full article